LBA59 Associations of ctDNA clearance and pathological response with neoadjuvant treatment in patients with resectable NSCLC from the phase III AEGEAN trial

Martin Reck, Daniel P. Gale, David H. Harpole, Janis M. Taube, Tetsuya Mitsudomi, Maximilian J. Hochmair, Thomas Winder, Zhen Zhu, Zhongwu Lai, Ross Stewart, Darren Hodgson, Gary J. Doherty, John V. Heymach